Status:
RECRUITING
Study of the Incidence of SARS-CoV-2 Infection (COVID-19)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Coronavirus Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective observational cohort study that will define the prevalence and incidence of CA-SARS-Cov2 infection using serological and PCR tests in a group of subjects during deconfinement. Th...
Eligibility Criteria
Inclusion
- Any major subject, voluntary, exposed to the public from 11 May 2020 informed of the study by partner institutions (Departmental Council 06), affiliated to a social security scheme,
Exclusion
- Subject protected by law under tutorship or guardianship, or who cannot participate in a clinical study under the terms of Article L. 1121-16 of the French Public Health Code
Key Trial Info
Start Date :
July 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04429594
Start Date
July 28 2020
End Date
December 31 2025
Last Update
June 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Nice Hospital
Nice, France, 06000